Literature DB >> 18409190

Altered expression of 12S/MT-RNR1, MT-CO2/COX2, and MT-ATP6 mitochondrial genes in prostate cancer.

Jesús Abril1, Miguel López de Heredia, Laura González, Ramon Clèries, Marga Nadal, Enric Condom, Fernando Aguiló, Montserrat Gómez-Zaera, Virginia Nunes.   

Abstract

BACKGROUND: Prostate cancer is one of the commonest cancers worldwide and is responsible for nearly 6% of all male cancer deaths. Despite this relevance, the mechanisms involved in the development and progression of this malignancy remain unknown. The involvement of polypeptides of the mitochondrial respiratory chain, the Krebs cycle and the glutathione antioxidant system in this type of cancer has been previously described, although no publication has focused on the expression of mitochondrial genes in the prostate of PCa patients.
METHODS: We have determined by reverse transcription-quantitative PCR (RT-qPCR) the relative amount of the transcripts of eight mitochondrial genes (MT-ND2, MT-ND4, MT-ND6, MT-CYB, 12S/MT-RNR1, 16S/MT-RNR2, MT-CO2/COX2, MT-ATP6), and four nuclear genes (COX11, GSR, CS, ACO2), all of them key players in the normal metabolism of mitochondria. Additionally we analyzed the expression of Cyclophilin A (PPIA).
RESULTS: We observed differential expression of mitochondrial 12S/MT-RNR1, MT-CO2/COX2, and MT-ATP6 transcripts in tumor samples when compared to their paired normal samples.
CONCLUSIONS: The amount of mitochondrial 12S/MT-RNR1, MT-CO2/COX2, and MT-ATP6 transcripts is significantly decreased in tumor samples when compared to their paired normal sample, suggesting that mitochondrial gene expression is altered in PCa. (c) 2008 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18409190     DOI: 10.1002/pros.20771

Source DB:  PubMed          Journal:  Prostate        ISSN: 0270-4137            Impact factor:   4.104


  11 in total

1.  Somatic mutations throughout the entire mitochondrial genome are associated with elevated PSA levels in prostate cancer patients.

Authors:  Anita Kloss-Brandstätter; Georg Schäfer; Gertraud Erhart; Alexander Hüttenhofer; Stefan Coassin; Christof Seifarth; Monika Summerer; Jasmin Bektic; Helmut Klocker; Florian Kronenberg
Journal:  Am J Hum Genet       Date:  2010-12-10       Impact factor: 11.025

Review 2.  Mitochondrial subversion in cancer.

Authors:  Aditi Chatterjee; Santanu Dasgupta; David Sidransky
Journal:  Cancer Prev Res (Phila)       Date:  2011-05

3.  Mitochondrial haplogroups and control region polymorphisms are not associated with prostate cancer in Middle European Caucasians.

Authors:  Edith E Mueller; Waltraud Eder; Johannes A Mayr; Bernhard Paulweber; Wolfgang Sperl; Wolfgang Horninger; Helmut Klocker; Barbara Kofler
Journal:  PLoS One       Date:  2009-07-28       Impact factor: 3.240

4.  Expression of mitochondrial genes MT-ND1, MT-ND6, MT-CYB, MT-COI, MT-ATP6, and 12S/MT-RNR1 in colorectal adenopolyps.

Authors:  LaShanale Wallace; Sharifeh Mehrabi; Methode Bacanamwo; Xuebiao Yao; Felix O Aikhionbare
Journal:  Tumour Biol       Date:  2016-06-22

Review 5.  Regulation of mitochondrial respiratory chain biogenesis by estrogens/estrogen receptors and physiological, pathological and pharmacological implications.

Authors:  Jin-Qiang Chen; Patrick R Cammarata; Christopher P Baines; James D Yager
Journal:  Biochim Biophys Acta       Date:  2009-06-23

6.  MicroRNA-34a Encapsulated in Hyaluronic Acid Nanoparticles Induces Epigenetic Changes with Altered Mitochondrial Bioenergetics and Apoptosis in Non-Small-Cell Lung Cancer Cells.

Authors:  Malav Trivedi; Amit Singh; Meghna Talekar; Grishma Pawar; Parin Shah; Mansoor Amiji
Journal:  Sci Rep       Date:  2017-06-16       Impact factor: 4.379

7.  Moonlighting Proteins and Cardiopathy in the Spatial Response of MCF-7 Breast Cancer Cells to Tamoxifen.

Authors:  Abdulrab Ahmed M Alkhanjaf; Roberto Raggiaschi; Mark Crawford; Gabriella Pinto; Jasminka Godovac-Zimmermann
Journal:  Proteomics Clin Appl       Date:  2019-07-25       Impact factor: 3.494

8.  Impact of an MT-RNR1 Gene Polymorphism on Hepatocellular Carcinoma Progression and Clinical Characteristics.

Authors:  Yang-Hsiang Lin; Yu-De Chu; Siew-Na Lim; Chun-Wei Chen; Chau-Ting Yeh; Wey-Ran Lin
Journal:  Int J Mol Sci       Date:  2021-01-23       Impact factor: 5.923

9.  Receptor-Tyrosine Kinase Inhibitor Ponatinib Inhibits Meningioma Growth In Vitro and In Vivo.

Authors:  Tao Yu; Junguo Cao; Montadar Alaa Eddine; Mahmoud Moustafa; Andreas Mock; Cihan Erkut; Amir Abdollahi; Rolf Warta; Andreas Unterberg; Christel Herold-Mende; Gerhard Jungwirth
Journal:  Cancers (Basel)       Date:  2021-11-24       Impact factor: 6.639

10.  Assessment of cytochrome C oxidase dysfunction in the substantia nigra/ventral tegmental area in schizophrenia.

Authors:  Matthew W Rice; Kristen L Smith; Rosalinda C Roberts; Emma Perez-Costas; Miguel Melendez-Ferro
Journal:  PLoS One       Date:  2014-06-18       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.